Alaunos Therapeutics (TCRT) Other Accumulated Expenses (2011 - 2022)
Alaunos Therapeutics' (TCRT) quarterly Other Accumulated Expenses came in at $169000.0 in Q4 2022, up 1.2% YoY from $167000.0 in Q4 2021, and up 1.2% on a QoQ basis from $167000.0 in Q4 2021.
Alaunos Therapeutics (TCRT) Other Accumulated Expenses (2011 - 2022) Analysis & Trends
Alaunos Therapeutics (TCRT) has 9 years of Other Accumulated Expenses data on file, last reported at $169000.0 in Q4 2022.
- Quarterly Other Accumulated Expenses rose 1.2% year-over-year to $169000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $169000.0 (up 1.2% YoY) and the FY2022 annual result came in at $169000.0, up 1.2% from the prior year.
- Other Accumulated Expenses grew to $169000.0 in Q4 2022, from $167000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $169000.0 in Q4 2022 to a low of $167000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 169,000.00 |
| Dec 31, 2021 | 167,000.00 |
| Dec 31, 2017 | 222,000.00 |
| Dec 31, 2016 | 28,000.00 |
| Dec 31, 2015 | 66,000.00 |
| Dec 31, 2014 | 226,000.00 |
| Dec 31, 2013 | 230,000.00 |
| Dec 31, 2012 | 903,000.00 |
| Dec 31, 2011 | 347,000.00 |